Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial

Peter Chen; Gerhard Behre; Corey Hebert; Princy Kumar; Lisa Farmer Macpherson; Peita Louise Graham-Clarke; Inmaculada De La Torre; Russell M Nichols; Matthew M Hufford; Dipak R Patel; April N Naegeli

Open Forum Infectious Diseases (2022) - Comments
doi: 10.1093/ofid/ofac172 issn: 2328-8957 pubmed: 35493124

Peter Chen, Gerhard Behre, Corey Hebert, Princy Kumar, Lisa Farmer Macpherson, Peita Louise Graham-Clarke, Inmaculada De La Torre, Russell M Nichols, Matthew M Hufford, Dipak R Patel, April N Naegeli

Go to article
Go to preprint

Oxford University Press (OUP)